A Study of the Role of Proteinorrhoea (protein-losing Gastro-enteropathy) in Bilharzial Hepatic Fibrosis.
نویسندگان
چکیده
Hypoproteinaemia is present in many patients suffering from schistosomal (bilharzial) hepatic fibrosis, especially when associated with ascites. In most patients with hypoproteinaemia undergoing treatment on a well-balanced diet the fall in serum proteins can be corrected except in a small group of cases. Hypoproteinaemia, mainly hypoalbuminaemia, cannot be ascribed to diminished protein synthesis, which remains within normal limits as does parenchymal liver function in patients with bilharzial hepatic fibrosis till the terminal stage (Salah, 1962). Loss of proteins into the gastro-intestinal tract has been shown to be a major factor in the hypoproteinaemia associated with regional enteritis (Steinfeld, Davidson, and Gordon, 1957), ulcerative colitis (Holman, Nickel, and Sleizenger, 1959), sprue (Parkins 1960), gastric neoplasm (Schwartz and Jarnum, 1959), giant hypertrophy of the gastric mucosa (Chokas, 1959), hypertrophic gastritis (Citrin, Stirling, and Halsted, 1957), congestive heart failure, constrictive pericarditis (Davidson, Waldmann, Goodman, and Gordon, 1961), and the syndrome of idiopathic hypercatabolic hypoproteinaemia (Gordon, 1959; Schwartz and Jarnum, 1959). Several methods have been employed to study this phenomenon. Paper electrophoresis and immunophoresis have been used to determine the presence of autogenous human albumins and globulins in intestinal juices (Schwartz and Jarnum, 1959; Gross, Embree, Bally, Shipp, and Thorn, 1960). But such methods are mainly qualitative. Gordon (1959) used radio-iodinated polyvinylpyrrolidone and Schwartz and Thomsen (1957) radioiodinated human serum albumin, but Waldmann (1961) used 51Cr-labelled albumin in attempts to study intestinal protein loss quantitatively. MATERIAL AND METHODS
منابع مشابه
99mTc-MDP abdominal scintigraphy in a paediatric case of GI protein loss - A viable and simple alternate to HSA imaging
A nine-month old male child presented with low-grade fever, loose stools and facial puffiness. Clinically patient was otherwise normal except for a firm liver on palpation. The laboratory tests revealed hypoproteinemia (both albumin and globulin) and iron deficiency anemia. Differential diagnosis considered were: 1. Nephrotic syndrome, 2. Cystic fibrosis (in view of recurrent diarrhea and respi...
متن کاملGastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease.
AIMS Protein losing enteropathy is a serious complication of Fontan surgery. The aim of this study was to investigate gastro-intestinal protein loss in adults with congenital heart disease, both with and without Fontan surgery, and to correlate findings with systemic venous pressure. METHODS AND RESULTS Forty eight patients were studied. The first group included adult survivors of Fontan surg...
متن کاملThe protective role of deferoxamine in the prevention of doxorubicin-induced hepatic fibrosis in children: A randomized controlled clinical trial
Background: This study aimed to investigate the protective effects of Deferoxamine (DFO) against hepatic fibrosis in treatment of pediatric cancer patients. Methods: In this prospective randomized controlled trial, 61 treatment-naïve children (2-18 years) with different types of cancer who referred to a tertiary teaching hospital in South of Iran were enrolled. They were randomly assigned to 3...
متن کاملLETTER TO JMG Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib
Congenital disorders of glycosylation (CDG) are newly described inborn errors of metabolism involving glycan moiety synthesis. CDG Ib is caused by a deficiency of cellular phosphomannose isomerase (EC 5.4.2.28) resulting from the presence of mutations in the corresponding gene, MPI, 6 on chromosome 15 (mutation database: http:// www.med.kuleuven.ac.be/cdg/). CDG Ib differs clinically from the o...
متن کاملProtein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation type Ib.
Congenital disorders of glycosylation (CDG) are newly described inborn errors of metabolism involving glycan moiety synthesis. CDG Ib is caused by a deficiency of cellular phosphomannose isomerase (EC 5.4.2.28) resulting from the presence of mutations in the corresponding gene, MPI, 6 on chromosome 15 (mutation database: http:// www.med.kuleuven.ac.be/cdg/). CDG Ib differs clinically from the o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Gut
دوره 5 شماره
صفحات -
تاریخ انتشار 1964